Skip to main content
Log in

Zoledronic acid for secondary prevention of hip fractures cost effective

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Ramanau H, et al. Burden of Hip Fracture in Patients Aged 50 Years and Older: Disability-Adjusted Life- Years and Cost-Effectiveness Analysis in Belarus. 2020 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases : abstr. P578, 20 Aug 2020. Available from: URL: http://www.wco-iof-esceo.org/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zoledronic acid for secondary prevention of hip fractures cost effective. PharmacoEcon Outcomes News 863, 33 (2020). https://doi.org/10.1007/s40274-020-7187-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7187-5

Navigation